The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fausch, S. C.
Right arrow Articles by Kast, W. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fausch, S. C.
Right arrow Articles by Kast, W. M.
The Journal of Immunology, 2002, 169: 3242-3249.
Copyright © 2002 by The American Association of Immunologists

Human Papillomavirus Virus-Like Particles Do Not Activate Langerhans Cells: A Possible Immune Escape Mechanism Used by Human Papillomaviruses1

Steven C. Fausch, Diane M. Da Silva, Michael P. Rudolf2 and W. Martin Kast3

Cancer Immunology Program, Cardinal Bernardin Cancer Center, Loyola University Chicago, Maywood, IL 60153

High-risk human papillomaviruses are linked to several malignancies including cervical cancer. Because human papillomavirus-infected women do not always mount protective antiviral immunity, we explored the interaction of human papillomavirus with Langerhans cells, which would be the first APCs the virus comes into contact with during infection. We determined that dendritic cells, normally targeted by vaccination procedures and Langerhans cells, normally targeted by the natural virus equally internalize human papillomavirus virus-like particles. However, in contrast to dendritic cells, Langerhans cells are not activated by human papillomavirus virus-like particles, illustrated by the lack of: up-regulating activation markers, secreting IL-12, stimulating T cells in an MLR, inducing human papillomavirus-specific immunity, and migrating from epidermal tissue. Langerhans cells, like dendritic cells, can display all of these characteristics when stimulated by proinflammatory agents. These data may define an intriguing immune escape mechanism used by human papillomavirus and form the basis for designing optimal vaccination strategies.




This article has been cited by other articles:


Home page
 Clin. Cancer Res.Home page
A. P. Lepique, K. R. P. Daghastanli, I. M. Cuccovia, and L. L. Villa
HPV16 Tumor Associated Macrophages Suppress Antitumor T Cell Responses
Clin. Cancer Res., July 1, 2009; 15(13): 4391 - 4400.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
L. M. Fahey, A. B. Raff, D. M. Da Silva, and W. M. Kast
Reversal of Human Papillomavirus-Specific T Cell Immune Suppression through TLR Agonist Treatment of Langerhans Cells Exposed to Human Papillomavirus Type 16
J. Immunol., March 1, 2009; 182(5): 2919 - 2928.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
D. M. Da Silva, S. C. Fausch, J. S. Verbeek, and W. M. Kast
Uptake of Human Papillomavirus Virus-Like Particles by Dendritic Cells Is Mediated by Fc{gamma} Receptors and Contributes to Acquisition of T Cell Immunity
J. Immunol., June 15, 2007; 178(12): 7587 - 7597.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
D. M. LeBlanc, M. M. Barousse, and P. L. Fidel Jr.
Role for Dendritic Cells in Immunoregulation during Experimental Vaginal Candidiasis.
Infect. Immun., June 1, 2006; 74(6): 3213 - 3221.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
R. Yang, F. M. Murillo, M. J. Delannoy, R. L. Blosser, W. H. Yutzy IV, S. Uematsu, K. Takeda, S. Akira, R. P. Viscidi, and R. B. S. Roden
B Lymphocyte Activation by Human Papillomavirus-Like Particles Directly Induces Ig Class Switch Recombination via TLR4-MyD88
J. Immunol., June 15, 2005; 174(12): 7912 - 7919.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
R. Yang, C. M. Wheeler, X. Chen, S. Uematsu, K. Takeda, S. Akira, D. V. Pastrana, R. P. Viscidi, and R. B. S. Roden
Papillomavirus Capsid Mutation To Escape Dendritic Cell-Dependent Innate Immunity in Cervical Cancer
J. Virol., June 1, 2005; 79(11): 6741 - 6750.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
S. C. Fausch, L. M. Fahey, D. M. Da Silva, and W. M. Kast
Human Papillomavirus Can Escape Immune Recognition through Langerhans Cell Phosphoinositide 3-Kinase Activation
J. Immunol., June 1, 2005; 174(11): 7172 - 7178.
[Abstract] [Full Text] [PDF]

Home page
 J. Gen. Virol.Home page
L. Bousarghin, P. Hubert, E. Franzen, N. Jacobs, J. Boniver, and P. Delvenne
Human papillomavirus 16 virus-like particles use heparan sulfates to bind dendritic cells and colocalize with langerin in Langerhans cells
J. Gen. Virol., May 1, 2005; 86(5): 1297 - 1305.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
R. Yang, F. M. Murillo, H. Cui, R. Blosser, S. Uematsu, K. Takeda, S. Akira, R. P. Viscidi, and R. B. S. Roden
Papillomavirus-Like Particles Stimulate Murine Bone Marrow-Derived Dendritic Cells To Produce Alpha Interferon and Th1 Immune Responses via MyD88
J. Virol., October 15, 2004; 78(20): 11152 - 11160.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
A. de Jong, M. I. E. van Poelgeest, J. M. van der Hulst, J. W. Drijfhout, G. J. Fleuren, C. J. M. Melief, G. Kenter, R. Offringa, and S. H. van der Burg
Human Papillomavirus Type 16-Positive Cervical Cancer Is Associated with Impaired CD4+ T-Cell Immunity against Early Antigens E2 and E6
Cancer Res., August 1, 2004; 64(15): 5449 - 5455.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
R. T. Semnani, M. Law, J. Kubofcik, and T. B. Nutman
Filaria-Induced Immune Evasion: Suppression by the Infective Stage of Brugia malayi at the Earliest Host-Parasite Interface
J. Immunol., May 15, 2004; 172(10): 6229 - 6238.
[Abstract] [Full Text] [PDF]

Home page
 Ann OncolHome page
A. Mandic and T. Vujkov
Human papillomavirus vaccine as a new way of preventing cervical cancer: a dream or the future?
Ann. Onc., February 1, 2004; 15(2): 197 - 200.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
S. C. Fausch, D. M. Da Silva, and W. M. Kast
Differential Uptake and Cross-Presentation of Human Papillomavirus Virus-like Particles by Dendritic Cells and Langerhans Cells
Cancer Res., July 1, 2003; 63(13): 3478 - 3482.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2002 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2002 by The American Association of Immunologists, Inc. All rights reserved.